BRCA1/BRCA2 Hereditary Breast and Ovarian Cancer Syndrome
GEC-KO on the run: A 2-page, evidence-based summary for healthcare providers. Features a bottom line, red flags for a genomic assessment, associated cancer risk, benefits and limitations of genetic testing. (Updated April 2016)
GEC-KO Messenger: A 10-page, comprehensive evidence-based resource for healthcare providers. Features a bottom line, red flags for a genomic assessment, associated cancer risk, benefits and limitations of genetic testing, references and more. (Updated April 2016)
Point of Care tool: A two-part (I, II) tool to identify individuals likely to benefit from a genomic risk assessment (I) and those predicted to be at increased risk to carry a mutation in the BRCA1 or BRCA2 genes (II). (Updated July 2019)
GEC-KO aims to aid the practicing non-genetics health professional by providing informed opinions regarding genetic/genomic conditions, services and technologies that have been developed in a rigorous and evidence-based manner with periodic updating. The content on the GEC-KO site is for educational purposes only. No resource should be used as a substitute for clinical judgement. GEC-KO assumes no responsibility or liability resulting from the use of information contained herein.